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Purpose: Several dietary factors have been associated with glaucoma. Among them, dietary antioxidant intake (i.e.,
vitamin C and vitamin A) in association with glaucoma has been analyzed, but with mixed results. Genetic factors may
play a role in modulating the effect of dietary antioxidant intake on glaucoma; however, nutrigenetic studies in this field
are scarce. Our aim was to study the association between selected polymorphisms in key proteins related to vitamin C and
vitamin A concentrations and primary open-angle glaucoma (POAG).
Methods: We performed a case-control study matched for age, sex, and bodyweight. We recruited 300 subjects (150
POAG cases and 150 controls) from a Mediterranean population and determined the plasma concentrations of vitamin C
and vitamin A for each subject. We selected the following single-nucleotide polymorphisms (SNPs) in genes related to
vitamin A and vitamin C concentrations: rs176990 and rs190910 in the retinol-binding protein 1 (RBP1) gene; and
rs10063949 and rs1279683 in the Na+-dependent L-ascorbic acid transporters 1 and 2, respectively (encoded by the
SLC23A1 and SLC23A2 genes).
Results: We found a statistically significant association between the rs1279386 (A>G) SNP in SLC23A2 and POAG risk.
In the crude analysis, homozygous subjects for the G allele (GG subjects) had higher risk of POAG than other genotypes
(OR: 1.67; 95% CI: 1.03–2.71). This association remained statistically significant (p=0.010) after multivariate adjustment
for potential confounders. We also found that POAG patients had lower plasma vitamin C concentrations than control
subjects (9.9±1.7 µg/ml versus 11.7±1.8 µg/ml, p<0.001). Moreover, we consistently detected a significant association
between the rs1279386 SNP in SLC23A2 and plasma vitamin C concentrations: GG subjects had significantly lower
plasma vitamin C concentrations than the other genotypes (9.0±1.4 µg/ml versus 10.5±1.6 µg/ml, p<0.001 in POAG cases
and 10.9±1.6 µg/ml versus 12.1±1.8 µg/ml, p<0.001 in controls). The rs10063949 SNP in SLC23A1 was not associated
with either plasma vitamin C concentrations or POAG risk. Similarly, SNPs in RBP1 were not associated with vitamin A
concentrations or POAG risk.
Conclusions: The rs1279683 SNP in SLC23A2 was significantly associated with lower plasma concentrations of vitamin
C and with higher risk of POAG in GG subjects.
Glaucoma is a group of diseases in which the optic nerve
is damaged, leading to blindness. The most common form is
primary open-angle glaucoma (POAG) [1]. The main cause
of developing POAG is alteration in the eye tissues, of the
anterior  chamber,  involved  in  intraocular  pressure  (IOP)
regulation,  resulting  in  aqueous  humor  (AH)  outflow
impairment and ocular hypertension (OHT) [2]. Many factors
have been associated with an increased risk of developing this
disease,  including  age,  race,  myopia,  family  history,  and
several single-nucleotide polymorphisms (SNPs) in the genes
[3-8].
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Among the non-genetic factors that may be associated
with this optic neuropathy, those related to nutrition have
recently been emerging, but their importance is still unknown.
Recent studies suggest that nutritional factors may play a role
in the pathogenic mechanisms of glaucoma [9,10], and that
these factors could be related to modifications in the trabecular
meshwork (TM; vitamin C, glutathione) and to optic atrophy
(vitamin E) [11]. Because vitamins such as A and C might be
involved  in  the  progression  of  glaucomatous  optic
neuropathy, the nutritional status of patients is very important
in maintaining good eye health [12,13]. Moreover, from a
nutrigenetic point of view, SNPs can modulate the effect of
dietary  intake  on  POAG  risk,  but  this  field  remains
unexplored.
Vitamin A (retinol) is an essential nutrient in maintaining
ocular health. This vitamin plays a key role in the development
and proper functioning of vision (retinol helps maintain cells
and eye tissues, such as the retina) and prevents eye diseases
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2997[14,15].  A  lack  of  vitamin  A  can  lead  to  serious  ocular
problems:  loss  of  visual  acuity  after  dark,  dryness  of  the
conjunctiva,  inflammation  of  the  eyelids,  and  corneal
ulceration [16,17]. One of the genetic factors related to the
metabolism  and  functions  of  vitamin  A,  cellular  retinol-
binding protein type 1 (CRBP1), which is encoded by the
retinol-binding  protein  gene  (RBP1),  serves  to  safeguard
retinol homeostasis [18].
Vitamin  C  is  an  important  water-soluble  antioxidant
[19]. Its adequate consumption may prevent the development
of eye diseases, especially degenerative ones, like glaucoma.
With  regard  to  this,  a  recent  study  found  that  serum
concentrations  of  vitamin  C  were  significantly  lower  in
glaucoma  patients  than  in  healthy  controls  [20].  Plasma
concentrations of vitamin C are determined by dietary intake,
as well as by genetic factors. L-Ascorbic acid obtained from
the diet is transported across the cell membrane by sodium L-
ascorbic acid cotransporters (SVCTs). Two isoforms, SVCT1
(encoded by the SLC23A1 gene) and SVCT2 (encoded by the
SLC23A2  gene),  play  central  roles  in  the  absorption  and
accumulation of vitamin C in many tissues [21,22].
Thus,  the  aim  of  this  study  was  to  investigate  the
association  of  selected  SNPs  in  RBP1,  SLC23A1,  and
SLC23A2 with POAG and to test whether this potential effect
was mediated by the association of these polymorphisms with
plasma concentrations of vitamins A and C.
METHODS
Subjects and study design: We performed a matched case-
control study, in which the same number of POAG subjects
and control subjects from a Mediterranean population were
paired by gender, age (±2 years), and body mass index (BMI;
categorized  into  normal  weight,  overweight,  and  obese
subjects).  We  recruited  300  Caucasian  participants  (150
patients with POAG, 61 men and 89 women, with mean age
68±9 years; and 150 controls) from two health centers in the
city of Valencia (Spain): the University Hospital Dr. Peset,
Valencia (Department of Ophthalmology and Department of
Preventive  Medicine  &  Public  Health)  and  the  School  of
Medicine  of  the  University  of  Valencia  (Department  of
Preventive Medicine & Public Health). Review boards and
ethical committees of the University of Valencia approved the
protocols for this study, which complied with the Helsinki
guidelines on human research. Informed consent forms were
signed by all study participants.
Cases  were  subjects  with  POAG  diagnosed  by  an
ophthalmologist and were aged from 50 to 80 years. Controls
were subjects without ocular diseases (POAG, cataracts, age-
related macular degeneration, or severe myopia) and were
matched with POAG cases by sex, age, and BMI. Cases with
ocular  diseases  other  than  POAG,  such  as  rickets,
osteoporosis and osteomalacia, and/or aged outside the range
of  inclusion  were  excluded.  Controls  with  rickets,
osteoporosis  or  osteomalacia;  aged  outside  the  range  of
inclusion; and/or with a family history of glaucoma were
excluded.  POAG  patients  underwent  a  systematized
ophthalmic examination, including slit lamp biomicroscopy,
IOP measurement (with Goldmann applanation tonometry),
best corrected visual acuity, visual field performance (using
the 24–2 Swedish Interactive Threshold Algorithm [SITA;
Humphrey  Field  Analyzer  II;  Carl  Zeiss  Meditec,  Inc.,
Dublin,  CA]),  ocular  imaging  analysis  (using  optical
coherence tomography [Stratus OCT; Carl Zeiss Meditec,
Inc.]), and dilated stereoscopic fundus examination under a
78-  diopters  (D)  lens  with  simultaneous  optic  disc
photographs.  Data  on  duration  of  the  disease,  family
background,  therapy,  and  various  aspects  of  the
ophthalmological examination were registered using a self-
designed database. IOP was also measured in healthy controls.
POAG  cases  and  controls  completed  a  questionnaire
regarding socio-demographic, clinical, and lifestyle variables.
Biochemical  and  genetic  analysis:  Global  standards  for
patient  biosample  workflow,  transport,  storage,  and
proceedings were strictly followed. In both POAG cases and
controls,  whole  blood  samples  were  obtained  from  the
antecubital veins of the participants under fasting conditions
(10–11 h). Blood was collected into EDTA tubes (two 5-ml
tubes per subject, one for DNA extraction and the other for
obtaining plasma).
Genomic  DNA  was  extracted  from  blood  with  the
MagNA Pure LC DNA Isolation Kit (Life Sciences Corp.,
Branford,  CT).  Genotyping  of  the  following  SNPs  was
performed on a 7900HT Sequence Detection System (Applied
Biosystems,  Foster  City,  CA)  using  standard  TaqMan
fluorescent  allelic  discrimination  assays:  rs176990  and
rs190910 in RBP1, rs10063949 in SLC23A1, and rs1279683
in SLC23A2.
Plasma concentrations of vitamin C were measured using
the method of Li et al. [23]. Briefly, analyses were performed
using Shimadzu Scientific Instruments (SSI, Columbia, MD)
equipment with an LC-20AB delivery pump and a Coulochem
III (ESA, Chelmsford, MA) electrochemical detector, under
reversed phase conditions with a 4.6×250 mm, 5 µM YMC-
Pack ODS-AQ column (Waters Corp., Milford, MA). The
software used was LabSolutions 1.2 (SSI, Columbia, MD).
Compounds were eluted over an 18-min runtime at a flow rate
of  0.6  ml/min.  The  mobile  phase  consisted  of  methanol/
150 mM chloroacetate (3:97, v/v) and 2mM disodium EDTA
(pH adjusted to 3.0 with 10 N NaOH). Sample injection was
5 µl.
Vitamin  A  plasma  concentrations  were  measured
according  to  the  method  of  Ortega  et  al.  [24],  with
modifications. Briefly, analyses were performed in a Gilson
Medical Electronics HPLC system (Middleton, WI) with an
LC307 delivery pump, an LC142 electrochemical detector
(325  nm),  and  a  Shim-pack  CLC-ODS  C18  column
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2998(250 mm×6 mm). Compounds were eluted over a 20-min
runtime at a flow rate of 1 ml/min. The mobile phase consisted
of methanol/water (95:5, v/v), and sample injection was 50 µl.
Statistical analysis: Pearson’s χ2 test was used to compare
categorical  variables  and  to  check  Hardy–Weinberg
equilibrium  (HWE)  for  the  analyzed  SNPs.  The  normal
distribution of continuous variables was checked first. These
variables were analyzed using the Unpaired Student’s t-test (2
groups),  and  the  ANOVA  test  with  post-hoc  Bonferroni
correction was used (for more than 2 groups) to compare mean
differences  among  the  groups.  To  estimate  the  risk  of
glaucoma associated with the genotypes, logistic regression
models were fitted, and the odds ratios (OR) and their 95%
confidence  intervals  (CI)  were  estimated.  Univariate  and
multivariate  regression  models  were  also  fitted,  including
control for potential confounders (sex, age, BMI, tobacco
smoking, and alcohol drinking). Multivariate lineal regression
models were used to adjust continuous variables (vitamin
concentrations) for the potential confounders. The original
significance level was set at a p-value of 0.05 by a two-tailed
test, with the Bonferroni correction applied to compensate for
multiple comparisons. This approach consists of using an
adjusted alpha level equal to the original alpha level (0.05),
divided by the number of SNPs analyzed. In our case, the
adjusted alpha is 0.05/4=0.0125. The significance of each
uncorrected test was assessed at this level. PASW software
(version  17.0,  SPSS,  Inc.,  Chicago,  IL)  and  the  program
Haploview 3.32 were used for statistical analysis.
RESULTS
The general characteristics of all 150 POAG patients and their
paired  controls  are  shown  in  Table  1.  Call  rates  for  the
genotyped  SNPs  (rs176990  and  rs190910  in  RBP1,
rs10063949 in SLC23A1, and rs1279683 in SLC23A2) were
all 100%. Genotype distributions in the controls exhibited
TABLE 1. GENERAL CHARACTERISTICS OF POAG CASES AND CONTROLS.
Characteristics Cases (n=150) Controls (n=150) p
Females (%) 59.3 59.3 1.000
Age (years) 68±9 68±8 0.973
BMI (kg/m2) 27.5±4.7 27.4±4.9 0.801
Cup disk ratio 0.7 0.3 <0.001*
Smokers (%) 28 22 0.230
Alcohol consumers (%) 74 68 0.252
           *Statistically significant (p<0.0125) differences between cases and controls. BMI: Body mass index.
TABLE 2. GENOTYPIC FREQUENCIES OF THE RBP1, SLC23A1, AND SLC23A2 POLYMORPHISMS IN POAG CASES AND CONTROLS.
      Genotype frequencies (%)            
  Cases (n=150) Controls (n=150)
Gene SNP Alleles*
(1/2)
1/1 1/2 2/2 1/1 1/2 2/2 p1 OR**
(95%CI)
p2 p3
RBP1 rs176990 T/G 25% 43% 32% 19% 48% 33% 0.423 0.97 (0.60–
1.57)
0.972 0.826
RBP1 rs190910 A/T 20% 52% 28% 15% 53% 32% 0.514 0.83 (0.50–
1.36)
0.451 0.315
SLC23A1 rs10063949 T/C 34% 40% 26% 33% 44% 23% 0.727 1.19 (0.71–
2.03)
0.501 0.552
SLC23A2 rs1279683 A/G 20% 41% 39% 17% 55% 28% 0.044 1.67 (1.03–
2.71)
0.038 0.010***
         *Allele 1 is the ancestral allele. Allele 2 is the variant allele. **Odds ratio (OR) and 95% confidence interval (CI) for homozygous
         subjects for the variant allele (2) compared with the reference category (homozygotes and heterozygotes for the ancestral allele).
         p1: Uncorrected p value obtained in the corresponding χ2 test for the comparison of the genotype distribution between cases and
         controls. p2: Uncorrected p value obtained in the crude logistic regression analysis. p3: Uncorrected p value obtained in the
         multivariate logistic regression after adjustment for sex, age, BMI, tobacco smoking, and drinking. ***Statistically significant
         p value (p<0.0125) after the Bonferroni correction for multiple comparisons.
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2999Hardy–Weinberg equilibrium (p=0.920, p=0.306, p=0.178,
and  p=0.195  for  rs176990,  rs190910,  rs10063949,  and
rs1279683, respectively). In the POAG cases, all SNPs had p-
values >0.05 except for rs10063949 (p=0.018). Thus, none of
the  four  SNPs  deviated  from  HWE  in  POAG  cases  after
Bonferroni  correction  for  multiple  comparisons
(p>0.05/4=0.0125).
Table 2 shows the genotype frequencies of the four SNPs
in POAG cases and controls. For each SNP, we have first
indicated the genotypes for the ancestral allele, which was the
major  allele  only  for  rs10063949.  In  this  population,  the
ancestral allele was the minor allele for the other three SNPs.
After evaluation of the genotype distributions, and taking into
account the p-value obtained in the comparisons between
cases  and  controls,  we  grouped  homozygous  and
heterozygous subjects for the ancestral allele and compared
this group with homozygous subjects for the non-ancestral
(variant) allele. OR and 95% CI were estimated for each SNP.
The group of homozygous and heterozygous subjects for the
ancestral  allele  was  considered  as  the  reference  category.
Crude  and  multivariate  adjusted  p-values  were  estimated
(Table 2). The crude risk (OR) of POAG associated with the
GG genotype of SLC23A2 in comparison with AA + AG
subjects  was  1.67  [95%  CI  (1.03–2.71),  p=0.038].  After
adjustment  for  potential  confounders  (sex,  gender,  BMI,
tobacco smoking, and alcohol consumption), this estimation
reached statistical significance (p=0.010), taking into account
the significance of the threshold p-value (p=0.0125) after the
correction for multiple comparisons. We did not find any
significant association for the other SNPs.
We also analyzed the plasma concentrations of vitamin
C  and  A  for  significant  differences  between  cases  and
controls. Although plasma concentrations of vitamin A tended
to  be  lower  in  POAG  patients  than  in  control  subjects,
differences did not reach statistical significance (519.3±47.1
ng/ml in POAG cases versus 527.7±58.9 ng/ml in controls;
p=0.174;  Figure  1).  However,  plasma  concentrations  of
vitamin C were significantly lower in POAG patients than in
controls  (9.9±1.7  µg/ml  versus  11.7±1.8  µg/ml;  p<0.001;
Figure 2).
In addition, we tested the polymorphisms in the vitamin
C  cotransporters  for  association  with  plasma  vitamin  C
concentrations (Table 3). In both POAG cases (p<0.001) and
controls (p=0.001), we found a strong association between
rs1279683 in SLC23A2 and plasma vitamin C concentrations.
We also observed that homozygous subjects for the G allele
of  rs1279683  in  SLC23A2  (GG)  had  significantly  lower
(p<0.001)  vitamin  C  concentrations  than  carriers  of  the
ancestral  allele  (AA  +  AG).  This  association  remained
statistically  significant  (p<0.0125)  even  after  multivariate
adjustment  for  potential  confounders  (sex,  age,  BMI,
smoking,  and  drinking).  These  results  agreed  with  our
Figure  1.  Plasma  concentrations  of
vitamin A (ng/ml) in POAG cases and
controls. Differences between means in
cases and controls were not statistically
significant (p>0.05).
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3000previous observation when analyzing the association between
rs1279683  and  POAG  risk.  Moreover,  the  association  of
rs1279683 with higher POAG risk was mediated by the SNP’s
association  with  lower  plasma  vitamin  C  concentrations,
given that after multivariate adjustment for plasma vitamin C
concentrations,  rs1279683  did  not  reach  statistical
significance in the logistic regression model (OR: 0.73; 95%
CI: 0.41–1.29; p=0.277).
We did not observe any significant association between
the SNP in SLC23A1 and plasma vitamin C concentrations, or
between  the  SNPs  in  RBP1  and  plasma  vitamin  A
concentrations (Table 3).
DISCUSSION
The present study has revealed for the first time a significant
association between the rs1279683 (A>G) single-nucleotide
polymorphism (SNP) in SLC23A2 and higher risk of POAG
in homozygous carriers for the G allele (GG). The association
of POAG risk with this SNP appears to be affected by its
influence in determining plasma vitamin C concentrations, as
homozygous carriers of the G allele have significantly lower
plasma vitamin C concentrations than the other genotypes. As
far as we know, this is also the first time that a significant
association  between  the  rs1279683  polymorphism  in
SLC23A2  and  plasma  vitamin  C  concentration  has  been
reported in humans. Previous works have demonstrated the
relevance of this gene in animal models and cultured cells
[25,26]. Although rs1279683 is an intronic SNP, functional
assays of this variant have not been performed and it could be
in linkage disequilibrium with the causal variant, if we take
into account our observed results in terms of lower plasma
vitamin C concentrations in homozygous subjects for the G
allele, we can hypothesize that the G allele could be associated
with lower expression of SLC23A2.
Regarding the rs10063949 polymorphism in SLC23A1,
we did not find differences in genotype distribution between
the  POAG  patients  and  the  control  group.  Although  both
SLC23A1 and SLC23A2 codify for two isoforms of the sodium
L-ascorbic  acid  cotransporters,  and  both  have  important
functions related to ascorbic acid metabolism, SLC23A1 is
expressed in the digestive, reproductive, and urinary system
(not in the visual system). In contrast, SLC23A2 is highly
expressed in the eye [27,28], and our results are in agreement
with  this  tissue  specificity.  On  the  other  hand,  genetic
variations in the vitamin C transporter SLC23A2 have been
associated with several types of cancer [29-31], supporting the
relevance of this gene in antioxidant mechanisms.
Several  authors  have  demonstrated  the  existence  of
oxidative stress processes in POAG [32-34]. The cause of this
phenomenon  is  an  imbalance  between  production  of  free
Figure  2.  Plasma  concentrations  of
vitamin C (µg/ml) in POAG cases and
controls.  *Statistically  significant
(p<0.0125)  differences  of  means
between cases and controls.
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,radicals and antioxidant defenses, so that the body is unable
to  inhibit  the  cellular  damage  caused  by  reactive  oxygen
species (ROS).
Izzotti  et  al.  [35],  by  measuring  an  increase  in  8-
hydroxy-2'-deoxyguanosine, demonstrated the occurrence of
oxidative DNA damage in the trabecular meshwork (TM). In
addition, oxidative stress also appears to be related to the
neuronal death characteristic of POAG [36]. We observed
significantly  lower  plasma  levels  of  vitamin  C  in  POAG
patients than in healthy subjects. These results agree with
those of Yuki et al. [20], who found lower serum levels of
vitamin C in normal-tension glaucoma patients. Leite et al.
[37] studied the ascorbic acid concentration in the secondary
aqueous humor of glaucomatous patients, and found that it
was approximately twofold lower in comparison with the
primary  AH  of  glaucomatous  and  cataract  patients.  This
reduction  in  ascorbic  acid  (vitamin  C)  concentration  in
glaucoma patients is logical, since this vitamin has a high
antioxidant activity, and subjects with primary open-angle
glaucoma lack this capacity.
The other antioxidant vitamin studied, vitamin A, is very
important  in  maintaining  ocular  health  and  preventing
problems  like  vision  loss,  twilight  blindness,  cataracts,
xerophthalmia, and glaucoma [17]. In our study, although the
plasma vitamin A concentrations tended to be lower in POAG
patients than in controls, this difference was not statistically
significant. The higher complexity of vitamin A metabolism
over that of vitamin C may contribute to the observed results.
In agreement with our results, Yuki et al. [20] did not find
statistically  significant  differences  in  plasma  vitamin  A
concentration between glaucoma patients and controls. In the
present study, we also investigated two SNPs in RBP1. RBP1
is one of the carrier proteins involved in the transport of
retinol.  It  is  highly  expressed  in  the  eye  and  influences
photoreceptor outer segment assembly through a mechanism
unrelated to rhodopsin regeneration [38]. However, we did not
find  significant  associations  with  plasma  vitamin  A
concentration in terms of the studied SNPs, rs176990 and
rs190910.
In  conclusion,  the  results  of  our  study  support  the
important role of dietary intake of antioxidants, and certain
genetic polymorphisms that modulate their effects, in POAG
risk.  Specifically,  our  results  show  that  low  plasma
concentrations  of  vitamin  C,  and  SNP  rs1279683  in
SLC23A2 through its significant association with low plasma
vitamin  C  concentrations,  are  POAG  risk  factors.  More
nutrigenetic studies are required to confirm this association in
other populations, as well as to obtain further knowledge on
new gene–diet interactions in POAG pathology.
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